Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo1,2, Li Zhou2, Zhao Huang2
1School of Medicine, Ningbo University, Ningbo 315211, China.
Antioxidants (Basel, Switzerland)
|June 24, 2022
Summary
Cancer involves increased oxidative stress from reactive oxygen species (ROS). Antioxidant therapies show promise but lack proven clinical efficacy, necessitating further research for effective cancer treatment.
Area of Science:
- Oncology
- Biochemistry
Background:
- Cancer is linked to elevated oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidants.
- Increased ROS can drive carcinogenesis by causing mutations and activating pro-oncogenic pathways.
Purpose of the Study:
- To review the rationale and recent advances in antioxidant therapy for cancer.
- To explore targeting ROS with various antioxidant strategies.
- To provide insights into improving antioxidant therapy's clinical effectiveness.
Main Methods:
- Review of pre-clinical and clinical research on antioxidant therapy in cancer.
- Examination of nonenzymatic antioxidants (e.g., NRF2 activators, vitamins, N-acetylcysteine, GSH esters).
- Analysis of enzymatic antioxidants (e.g., NOX inhibitors, SOD mimics).
Main Results:
- Antioxidant therapy targeting ROS is a potential cancer treatment strategy.
- Numerous antioxidants show pre-clinical promise, but clinical efficacy is unproven.
- Research is ongoing to enhance the effectiveness of these therapies.
Conclusions:
- Targeting oxidative stress is a rational approach for cancer treatment.
- Further research and prospective therapeutic options are needed to improve clinical outcomes.
- Optimizing antioxidant therapy could expand its role in cancer care.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
01:46Electron Transport Chain: Complex I and II
14.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652